Comparative Pharmacokinetics of Trientine Dihydrochloride Capsules: A Randomized, Open-Label, Reference-Controlled, Two-Period Crossover Study in Healthy Volunteers
Open Access
- 9 September 2026
- journal article
- research article
- Published by Springer Nature in Drugs in R&D
- Vol. 26 (3) , 255-262
Abstract
No abstract availableKeywords
Funding Information
- Emcure Pharmaceuticals, India
This publication has 29 references indexed in Scilit:
- Clinical experience on switching trientine tetrahydrochloride to trientine dihydrochloride in Wilson disease patientsJIMD Reports, 2024
- A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver DiseasesHepatology, 2022
- Letter to the Editor: Does Augmenter of Liver Regeneration Deficiency Pave the Way for Nonalcoholic Steatohepatitis Progression?Hepatology, 2020
- Posters (Abstracts 289–2348)Hepatology, 2019
- Interchangeability of Generics—Experiences and Outlook Toward Pharmacokinetics Variability and Generic‐Generic SubstitutionClinical Pharmacology & Therapeutics, 2018
- Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson DiseaseHepatology, 2018
- The steady state pharmacokinetics of trientine in Wilson disease patientsEuropean Journal of Clinical Pharmacology, 2018
- Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King’s College Hospital and review of the literatureEuropean Journal of Pediatrics, 2008
- Diagnosis and treatment of Wilson disease: An updateHepatology, 2008
- Treatment of Wilson’s disease: What are the relative roles of penicillamine, trientine, and zinc supplementation?Current Gastroenterology Reports, 2001